Preventing Errors with Neuromuscular Blocking Agents

Author： Smetzer Judy L.   Cohen Michael R.  

Publisher： Joint Commission Resources

ISSN： 1553-7250

Source： Joint Commission Journal on Quality and Patient Safety, Vol.32, Iss.1, 2006-01, pp. : 56-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medication Errors Involving Neuromuscular Blocking Agents

By Santell John P.  

Joint Commission Journal on Quality and Patient Safety, Vol. 32, Iss. 8, 2006-08 ,pp. : 470-475

Joint Commission Resources

Access to resources Recommend Favorite

ASCIA‐P26: MORPHINE AND PHOLCODINE SPECIFC IGE TESTING HAS LIMITED UTILITY IN THE DIAGNOSIS OF HYPERSENSITIVITY TO BENZYLISOQUINOLINE NEUROMUSCULAR BLOCKING AGENTS

By  

INTERNAL MEDICINE JOURNAL, Vol. 46, Iss. S4, 2016-09 ,pp. : 12-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Red plunger syringes for neuromuscular blocking drugs

By  

ANAESTHESIA, Vol. 70, Iss. 1, 2015-01 ,pp. : 107-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Documenting facemask ventilation before administering neuromuscular blocking drugs

By  

ANAESTHESIA, Vol. 73, Iss. 3, 2018-03 ,pp. : 389-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sentinel Event Alert: Preventing Pediatric Medication Errors

By  

JCAH Perspectives, Vol. 28, Iss. 5, 2008-05 ,pp. : 11-15

Joint Commission Resources

Access to resources Recommend Favorite